Skip to main content

A Basic Concept for PET-BNCT System

  • Chapter
Book cover Cancer Neutron Capture Therapy

Abstract

[10B]Boronophenylalanine (10B-BPA) has been used as a tumor selective boron carrier for boron neutron capture therapy (BNCT) in the treatment of malignant melanoma1. In the same way, it is thought to be a potential boron carrier for the treatment of malignant glioma2–4. Glioma infiltrates peripheral brain tissue and we always fall into the dilemma between resection and preservation of the infiltrated brain. Thus the treatment will be effective in these infiltrative tumors. In our studies of malignant glioma using positron emission tomography (PET), accumulation of 10B-BPA analog, [18F]fluoroboronophenylalanine (18F-10B-FBPA), in tumor lesion was dramatically revealed3. The metabolic analysis of this positron-emitting analog demonstrated that enhancement of the amino acid transport is a primary factor for the high accumulation3,5. [18F]Fluoroboronophenylalanine has been recognized as a compound that is incorporated into tumor cell selectively.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Y. Mishima, C. Honda, M. Ichihashi, H. Obara, J. Hiratsuka, H. Fukuda, I1. Karashima, T. Kobayashi, K. Kanda and Y. Yoshino, Treatment of malignant melanoma by single neutron capture treatment with melanoma-seeking 10B-Compound. Lancet 11: 388–389, 1989.

    Article  Google Scholar 

  2. J. A. Coderre, D.D.Joel, P.L. Micca, M.M. Nawrocky, D.N.Slatkin, Control ofintracerchra1 gliosarcomas in rats by boron neutron capture therapy with p-boronophenylalanine. Radiation Research 129: 290296, 1992.

    Google Scholar 

  3. S. Ueda, Y. Imahori, N. lbayashi, Y. Ohmori, K. Ono, T. Kobayashi, K. Akuta, The basic studies for boron neutron capture therapy (BNCT) of brain tumor using boronophenylalaninc. KURRI Prog. Rep. (Osaka): 304–305, 1992.

    Google Scholar 

  4. Y. Imahori, S. Ueda, N. lbayashi, Y. Ohmori, Metabolic evaluation of malignant brain tumor using ‘8F–10BPA by positron emission tomography to determine the feasibility of boron neutron therapy [abstract]. International Congress of Radiation Oncology: 285, 1993.

    Google Scholar 

  5. Y. Mishima, Y. Imahori, C. Honda, S. Ueda, T. Ido, In vivo diagnosis of human malignant melanoma using specific melanoma-seeking 18F-compound with positron emission tomography. Kyoto University Research Reactor Institute - Technical Report - (Osaka) 374,1–10, 1993.

    Google Scholar 

  6. Y. Mishima, Investigation for the extended application of melanoma boron neutron capture therapy. Kyoto University Research Reactor Institute–Technical Report- (Osaka) 356, 192–199, 1991.

    Google Scholar 

  7. S. Ueda, Y. Imahori, Y. Ohmori, E. Yoshino, K. Ono, T. Kobayashi, M. Takagaki, Y. Oda, T. Ido, Y. Mishima, Positron emission tomography and boron neutron capture therapy system to the patient with brain tumor -The first clinical trial using BPA-. In: Cancer Neutron Capture Therapy, Y. Mishima, ed., pp. 823–828 Plenum, New York, 1996.

    Google Scholar 

  8. S. C. Huang, M. E. Phelps, E. J. Hoffman, K. Sideris, C. J. Sel in, D. E. Kuhl, Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol 238: E69 - E82, 1980.

    PubMed  CAS  Google Scholar 

  9. K. Ishiwata, M. Shiono, K. Kubota, K. Yoshino, J. Hatazawa, T. Ido, C. Monda, M. Ichihashi and Y. Mishima, A unique in vivo assessment of 4-[’°B]borono-L-phenylalanine in tumor tissues for boron neutron capture therapy of malignant melanomas using positron emission tomography and 4-borono-2[1sF]fluoro-L-phenylalaniIle. Melanoma Res. 2: 171–179, 1992.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer Science+Business Media New York

About this chapter

Cite this chapter

Imahori, Y. et al. (1996). A Basic Concept for PET-BNCT System. In: Mishima, Y. (eds) Cancer Neutron Capture Therapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9567-7_99

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-9567-7_99

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-9569-1

  • Online ISBN: 978-1-4757-9567-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics